PK/PD in Drug Discovery and Development MasterClass - US edition

This online masterclass will provide a review of the PK processes and of PD studies from a pharmacological perspective.

14-17 May, 2024, Virtual

Starting time – EDT 10:00 a.m. | UTC 15:00 p.m. | CEST 16:00 p.m.

Overview

The primary objective of PK/PD modeling is the prediction of the time course of the drug effect and its relation to dose and exposure. PK/PD modeling has become a key success factor in drug R&D. PK/PD represents and extremely useful tool for the selection of drug candidates, their optimization, and for maximal exploitation of early clinical studies for an optimal design of pivotal Phase 3 trials. PK/PD relies on prior in vitro bioassays, and animal, and early clinical studies. PK/PD modeling is part of pharmacometrics and can be based also on the pathophysiological mechanisms and progression of the disease to predict therapeutic effects.

The course will provide a review of the PK processes and of PD studies from a pharmacological perspective. Preclinical PK/PD studies including the role of radiolabelled studies and the evaluation of pharmacologically active and/or toxic metabolites and toxicokinetics will be described.

#masterclass     #glceurope      #pharmaonlinetraining      #globalleadingconferences       #PKPDdrugdiscovery

RECOMMENDATION

Who should attend?

This course has been specifically designed to address the needs of those working in
the following areas:

• Regulatory

• Medical Affairs

• Licensing

• Project Management

• Outsourcing

• Pre-clinical Discovery and Development

• Clinical Research and Development

• Medical Writing